Stage-specific inhibition of mammary carcinogenesis by 1α-hydroxyvitamin D5
- 31 October 2004
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (15) , 2331-2337
- https://doi.org/10.1016/j.ejca.2004.05.025
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Ligand Structure—Function Relationships in the Vitamin D Endocrine System from the Perspective of Drug Development (Including Cancer Treatment)Published by Springer Nature ,2003
- Vitamin D Analogs and Breast CancerPublished by Springer Nature ,2003
- Antiproliferative role of vitamin D and its analogs – a brief overviewMolecular and Cellular Biochemistry, 2003
- Discovery of cancer preventive agents from natural products: from plants to prevention.Current Oncology Reports, 2002
- Chemoprevention: an essential approach to controlling cancerNature Reviews Cancer, 2002
- Vitamin D and cancerThe Journal of Nutritional Biochemistry, 2002
- Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer.Endocrine-Related Cancer, 2002
- Cancer Chemoprevention Using Natural Vitamin D and Synthetic AnalogsAnnual Review of Pharmacology and Toxicology, 2001
- Characterization of a Novel Analogue of 1α,25(OH)2-Vitamin D3 with Two Side Chains: Interaction with Its Nuclear Receptor and Cellular ActionsJournal of Medicinal Chemistry, 2000
- Progress in Cancer Chemoprevention: Development of Diet-Derived Chemopreventive AgentsJournal of Nutrition, 2000